Takeda Pharmaceutical (TAK) Return on Assets [ROA] (2019 - 2026)
Takeda Pharmaceutical (TAK) recorded Return on Assets [ROA] of 0.59% in the quarter ended Jun 30, 2026, down 1.95 percentage points from 2.54% a year earlier and down 0.14 percentage points from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Return on Assets [ROA] (2019 - 2026) Analysis & Trends
For the year ended Mar 31, 2026, Takeda Pharmaceutical reported Return on Assets [ROA] of -1.03%, down 1.74 percentage points from the prior year.
- Annual Return on Assets [ROA] has declined for three straight years, with a five-year change of -3.99 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, Return on Assets [ROA] came in at 0.72% in the year ended Mar 31, 2025 (-0.25 pp), 0.96% in the year ended Mar 31, 2024 (-1.17 pp), 2.13% in the year ended Mar 31, 2023 (+0.41 pp) and 1.71% in the year ended Mar 31, 2022 (-1.25 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Return on Assets [ROA] in data going back to the quarter ended Mar 31, 2019.
- On a year-over-year basis, Return on Assets [ROA] has declined for eight consecutive quarters, with an average year-over-year change of -1.25 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 1.60 percentage points in the quarter ended Mar 31, 2022, against a drop of 2.07 percentage points in the quarter ended Jun 30, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.73% (quarter ended Mar 31, 2026), 0.75% (quarter ended Dec 31, 2025) and 2.53% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 0.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.59% |
| Mar 31, 2026 | 0.73% |
| Dec 31, 2025 | 0.75% |
| Sep 30, 2025 | 2.53% |
| Jun 30, 2025 | 2.54% |
| Mar 31, 2025 | 2.25% |
| Dec 31, 2024 | 2.02% |
| Sep 30, 2024 | 2.85% |
| Jun 30, 2024 | 3.34% |
| Mar 31, 2024 | 3.52% |
| Dec 31, 2023 | 3.65% |
| Sep 30, 2023 | 4.05% |
| Jun 30, 2023 | 2.56% |
| Mar 31, 2023 | 2.88% |
| Dec 31, 2022 | 3.27% |
| Sep 30, 2022 | 3.45% |
| Jun 30, 2022 | 4.64% |
| Mar 31, 2022 | 4.56% |
| Jun 30, 2021 | 4.04% |
| Mar 31, 2021 | 2.96% |
API Access
Takeda Pharmaceutical Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();